Prescribing Information Cerebrolysin®

Abbreviated Prescribing Information - Cerebrolysin®

 

Name of the medicinal product: Cerebrolysin® - Solution for injection.
Qualitative and quantitative composition:One ml contains 215.2 mg of Cerebrolysin® concentrate in aqueous solution.
List of excipients:Sodium hydroxide and water for injection
Therapeutic indications: 

For treatment of cerebrovascular disorders.
Especially in the following indications: Senile dementia of Alzheimer’s type. Vascular dementia. Stroke. Craniocerebral trauma (commotio and contusio).

Contraindications:Hypersensitivity to one of the components of the drug, epilepsy, severe renal impairment. 
Marketing Authorisation Holder: EVER Neuro Pharma GmbH, A-4866 Unterach 


Only available on prescription and in pharmacies

More information about pharmaceutical form, posology and method of administration, special warnings and precautions for use, interaction with other medicinal products and other forms of interaction, fertility, pregnancy and lactation, effects on ability to drive and use machines, undesirable effects, overdose, pharmacodynamics properties, pharmacokinetic properties, preclinical safety data, incompatibilities, shelf life, special precautions for storage, nature and contents of the container and special precautions for disposal is available in the summary of product characteristics.


This information is based on the Austrian Summary of Product Characteristics. The prescribing information in your country may vary; please consult your local prescribing information and/or contact your local EVER representative.